COVID‑19 Saliva Antigen Test
SARS‑CoV‑2 infection
Pre‑clinicalActive
Key Facts
About Salignostics
Israeli startup delivering CE‑approved saliva‑based rapid tests for home and point‑of‑care diagnostics.
View full company profileTherapeutic Areas
Other SARS‑CoV‑2 infection Drugs
| Drug | Company | Phase |
|---|---|---|
| GammaFlu‑COVID | Gamma Vaccines | Preclinical |